Compare · PBAX vs SONY
PBAX vs SONY
Side-by-side comparison of Phoenix Biotech Acquisition Corp. (PBAX) and Sony Group Corporation (SONY): market cap, price performance, sector, and recent activity on the wire.
Summary
- PBAX operates in Industrials, while SONY operates in Consumer Staples - the two are in different parts of the market.
- SONY is the larger of the two at $121.05B, about 531.5x PBAX ($227.7M).
- SONY has hit the wire 2 times in the past 4 weeks while PBAX has been quiet.
- SONY has more recent analyst coverage (17 ratings vs 0 for PBAX).
- Company
- Phoenix Biotech Acquisition Corp.
- Sony Group Corporation
- Price
- $5.45+14.26%
- $20.27-1.12%
- Market cap
- $227.7M
- $121.05B
- 1M return
- -
- -1.39%
- 1Y return
- -
- -19.79%
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 0
- 2
- Recent ratings
- 0
- 17
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.
Sony Group Corporation
Sony Group Corporation designs, develops, produces, and sells electronic equipment, instruments, and devices for the consumer, professional, and industrial markets worldwide. The company distributes software titles and add-on content through digital networks; network services related to game, video, and music content; and home and portable game consoles, packaged software, and peripheral devices. It also develops, produces, markets, and distributes recorded music; publishes music; and produces and distributes animation titles, game applications based on animation titles, and various services for music and visual products. In addition, the company produces, acquires, and distributes live-action and animated motion pictures for theatrical release, as well as scripted and animated series, unscripted reality or light entertainment, daytime serials, game shows, television movies, and miniseries and other television programs; operates a visual effects and animation unit; manages a studio facility; and operates television and digital networks, and post-production facilities. Further, it researches, develops, designs, produces, markets, distributes, sells, and services televisions, and video and sound products; interchangeable lens, compact digital, and consumer and professional video cameras; projectors and medical equipment; mobile phones, tablets, accessories, and applications; and metal oxide semiconductor image sensors, charge-coupled devices, large-scale integration systems, and other semiconductors. Additionally, it offers Internet broadband network services; creates and distributes content for PCs and mobile phones; and provides life and non-life insurance, banking, and other services, as well as batteries, recording media, and storage media products. The company was formerly known as Sony Corporation and changed its name to Sony Group Corporation in April 2021. Sony Group Corporation was incorporated in 1946 and is headquartered in Tokyo, Japan.
Latest PBAX
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)
- New insider Corey Daniel claimed ownership of 671,470 shares (SEC Form 3) (Amendment)
- SEC Form D filed by Phoenix Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- SEC Form 4 filed by Laporte Kathleen (Amendment)
- Atwood Brian G acquired 248,735 shares (SEC Form 4) (Amendment)
- SEC Form SC 13D/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- Loewy Caroline M acquired 5,828 shares (SEC Form 4)
- Kosacz Barbara acquired 5,828 shares (SEC Form 4)
Latest SONY
- SEC Form 6-K filed by Sony Group Corporation
- SEC Form 6-K filed by Sony Group Corporation
- SEC Form 3 filed by new insider Tanaka Kenji
- SEC Form 3 filed by new insider Iwakami Atsuhiro
- SEC Form 6-K filed by Sony Group Corporation
- SEC Form 6-K filed by Sony Group Corporation
- SEC Form 6-K filed by Sony Group Corporation
- SEC Form 3 filed by new insider Ahuja Ravi
- SEC Form 3 filed by new insider Stringer Robert Adrian
- SEC Form 3 filed by new insider Nishino Hideaki